Merck & Co. Inc. (MRK) Beats the Street
-- Company Announces Full-Year 2007 Non-GAAP EPS of $3.20 and Fourth-Quarter Non-GAAP EPS of $0.80, Excluding Certain Previously Disclosed Items; Full-Year GAAP EPS of $1.49 and Fourth-Quarter GAAP EPS of $(0.75)
-- Worldwide Product Revenue Growth Driven by Performance of SINGULAIR, JANUVIA, GARDASIL and VARIVAX
-- Merck Reaffirms Full-Year 2008 Non-GAAP EPS Range of $3.28 to $3.38, Excluding Certain Items; Revised 2008 GAAP EPS Range of $3.80 to $4.00
-- Worldwide Product Revenue Growth Driven by Performance of SINGULAIR, JANUVIA, GARDASIL and VARIVAX
-- Merck Reaffirms Full-Year 2008 Non-GAAP EPS Range of $3.28 to $3.38, Excluding Certain Items; Revised 2008 GAAP EPS Range of $3.80 to $4.00
Labels: Merck and Co. Inc., MRK
posted by Stock Administrator @ 7:30 AM
0 Comments:
Post a Comment
<< Home